The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids on p38 MAPK in Asthma
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
To test whether simvastatin has an additional anti-inflammatory effects on p38 MAPK, a
signaling molecule for inflammation in inhaled steroid-treated asthmatics.